Clincosm LogoSign in Get a demo

Alzheimer's Disease

Showing NaN - NaN of 79
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alzheimer's Disease Trial in Worldwide (Lanabecestat, Placebo)

Terminated
Has Results
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +261 more
Nov 19, 2019

Alzheimer's Disease Trial in Worldwide (Lanabecestat)

Terminated
Has Results
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +132 more
Nov 19, 2019

Alzheimer's Disease Trial in Worldwide (Group 1 ELND005, Group 2 ELND005)

Terminated
Has Results
  • Alzheimer's Disease
  • Group 1 ELND005
  • Group 2 ELND005
  • Birmingham, Alabama
  • +45 more
Oct 17, 2019

Alzheimer's Disease Trial in Canada, United States (ELND005 (scyllo-inositol))

Completed
Has Results
  • Alzheimer's Disease
  • ELND005 (scyllo-inositol)
  • Phoenix, Arizona
  • +37 more
Oct 17, 2019

Alzheimer's Disease Trial in Worldwide (ELND005, Placebo)

Completed
Has Results
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +69 more
Oct 17, 2019

Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)

Terminated
Has Results
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +192 more
Sep 25, 2019

Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)

Terminated
Has Results
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +197 more
Sep 25, 2019

Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)

Terminated
Has Results
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +146 more
Sep 25, 2019

Alzheimer's Disease Trial in Toronto (Personalized Exercise Regimen)

Unknown status
  • Alzheimer's Disease
  • Personalized Exercise Regimen
  • Toronto, Ontario, Canada
    Toronto Western Hospital, WW5-449
Sep 24, 2019

Alzheimer's & Parkinson's Disease & Frontotemporal Lobar

Unknown status
  • Alzheimer's Disease
  • +2 more
  • Observational Study
  • Toronto, Ontario, Canada
    Toronto Western Hospital, University Health Network
Apr 15, 2019

Alzheimer's Disease Trial in Toronto (Repetitive Transcranial Magnetic Stimulation, Repetitive Transcranial Magnetic Stimulation

Completed
  • Alzheimer's Disease
  • Repetitive Transcranial Magnetic Stimulation
  • Repetitive Transcranial Magnetic Stimulation - Sham
  • Toronto, Ontario, Canada
    Center for Addiction and Mental Health
Feb 27, 2019

Alzheimer's Disease Trial in Canada, Puerto Rico, United States (Dimebon, Placebo)

Completed
Has Results
  • Alzheimer's Disease
  • Mobile, Alabama
  • +117 more
Nov 6, 2018

Alzheimer's Disease Trial in Worldwide (RVT-101, Placebo)

Completed
Has Results
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +196 more
Nov 8, 2018

Alzheimer's Disease Trial in Worldwide (250mg rilapladib, )

Completed
Has Results
  • Alzheimer's Disease
  • 250mg rilapladib
  • placebo
  • Sofia, Bulgaria
  • +29 more
Aug 7, 2018

Alzheimer's Disease Trial in Worldwide (Idalopirdine 60 mg)

Completed
Has Results
  • Alzheimer's Disease
  • Idalopirdine 60 mg
  • Birmingham, Alabama
  • +257 more
Aug 9, 2018

Apathy, Alzheimer's Disease Trial in Baltimore, Charleston, Toronto (Methylphenidate, , Psychosocial intervention)

Completed
Has Results
  • Apathy
  • Alzheimer's Disease
  • Baltimore, Maryland
  • +2 more
Jun 7, 2018

Alzheimer's Disease Trial in Worldwide (TRx0237 200 mg/day, Placebo)

Completed
  • Alzheimer's Disease
  • TRx0237 200 mg/day
  • Placebo
  • Phoenix, Arizona
  • +94 more
Mar 12, 2018

Alzheimer's Disease Trial in Worldwide (Placebo, Idalopirdine)

Completed
Has Results
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +161 more
Jan 23, 2018

Alzheimer's Disease Trial in Toronto (Paired Associative Stimulation, Paired Associative Stimulation-Control)

Completed
  • Alzheimer's Disease
  • Paired Associative Stimulation
  • Paired Associative Stimulation-Control
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health
Jan 22, 2018

Alzheimer's Disease Trial in Worldwide (SB-742457 15mg, SB-742457 35mg, Placebo)

Completed
Has Results
  • Alzheimer's Disease
  • SB-742457 15mg
  • +3 more
  • Litchfield Park, Arizona
  • +101 more
Nov 3, 2017

Alzheimer's Disease Trial in Worldwide (Rosiglitazone Extended Release 2mg, Rosiglitazone Extended Release 8mg, Placebo)

Completed
Has Results
  • Alzheimer's Disease
  • Rosiglitazone Extended Release 2mg
  • +3 more
  • Litchfield Park, Arizona
  • +248 more
Oct 23, 2017

Alzheimer's Disease Trial in Worldwide (Rosiglitazone XR)

Terminated
Has Results
  • Alzheimer's Disease
  • Rosiglitazone XR
  • Litchfield Park, Arizona
  • +271 more
Oct 11, 2017

Alzheimer's Disease Trial in Worldwide (Placebo, Idalopirdine)

Completed
Has Results
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +136 more
Aug 22, 2017

Alzheimer's Disease Trial in Worldwide (Rosiglitazone Extended Release 2mg, Rosiglitazone Extended Release 8mg, Placebo)

Completed
Has Results
  • Alzheimer's Disease
  • Rosiglitazone Extended Release 2mg
  • +2 more
  • Sun City, Arizona
  • +193 more
Aug 3, 2017

Alzheimer's Disease Trial in Worldwide (MABT5102A, )

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +91 more
Jul 10, 2017